Dysplasia and cancer in inflammatory bowel disease

Robert J. Basseri, Benjamin Basseri, Konstantinos Papadakis

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Inflammatory bowel disease (IBD) is a chronic gastrointestinal disease associated with an increased risk of colorectal cancer (CRC). Although CRC occurs in a minority of IBD patients (1%), it carries a high mortality and accounts for 20% of IBD-related mortality. Established risk factors for the development of CRC in IBD include disease duration of 8 years or more, family history of CRC, extensive colitis and primary sclerosing cholangitis. Meticulous colonoscopy and anti-inflammatory medications can reduce the risk of developing CRC. The future of IBD surveillance involves the use of novel endoscopic techniques (chromoendoscopy, narrow-band imaging, confocal laser endomicroscopy and autofluorescence) to enhance colonoscopic accuracy, in concert with chemopreventative medications to help reduce the risk of CRC in IBD.

Original languageEnglish (US)
Pages (from-to)59-66
Number of pages8
JournalExpert Review of Gastroenterology and Hepatology
Volume5
Issue number1
DOIs
StatePublished - Feb 1 2011
Externally publishedYes

Fingerprint

Inflammatory Bowel Diseases
Colorectal Neoplasms
Neoplasms
Narrow Band Imaging
Sclerosing Cholangitis
Mortality
Gastrointestinal Diseases
Colitis
Colonoscopy
Crohn Disease
Lasers
Chronic Disease
Anti-Inflammatory Agents

Keywords

  • colorectal cancer
  • dysplasia
  • IBD
  • inflammatory bowel disease

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Dysplasia and cancer in inflammatory bowel disease. / Basseri, Robert J.; Basseri, Benjamin; Papadakis, Konstantinos.

In: Expert Review of Gastroenterology and Hepatology, Vol. 5, No. 1, 01.02.2011, p. 59-66.

Research output: Contribution to journalReview article

@article{a0052a6fa6d641b894ae55be57d97225,
title = "Dysplasia and cancer in inflammatory bowel disease",
abstract = "Inflammatory bowel disease (IBD) is a chronic gastrointestinal disease associated with an increased risk of colorectal cancer (CRC). Although CRC occurs in a minority of IBD patients (1{\%}), it carries a high mortality and accounts for 20{\%} of IBD-related mortality. Established risk factors for the development of CRC in IBD include disease duration of 8 years or more, family history of CRC, extensive colitis and primary sclerosing cholangitis. Meticulous colonoscopy and anti-inflammatory medications can reduce the risk of developing CRC. The future of IBD surveillance involves the use of novel endoscopic techniques (chromoendoscopy, narrow-band imaging, confocal laser endomicroscopy and autofluorescence) to enhance colonoscopic accuracy, in concert with chemopreventative medications to help reduce the risk of CRC in IBD.",
keywords = "colorectal cancer, dysplasia, IBD, inflammatory bowel disease",
author = "Basseri, {Robert J.} and Benjamin Basseri and Konstantinos Papadakis",
year = "2011",
month = "2",
day = "1",
doi = "10.1586/egh.10.77",
language = "English (US)",
volume = "5",
pages = "59--66",
journal = "Expert Review of Gastroenterology and Hepatology",
issn = "1747-4124",
publisher = "Expert Reviews Ltd.",
number = "1",

}

TY - JOUR

T1 - Dysplasia and cancer in inflammatory bowel disease

AU - Basseri, Robert J.

AU - Basseri, Benjamin

AU - Papadakis, Konstantinos

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Inflammatory bowel disease (IBD) is a chronic gastrointestinal disease associated with an increased risk of colorectal cancer (CRC). Although CRC occurs in a minority of IBD patients (1%), it carries a high mortality and accounts for 20% of IBD-related mortality. Established risk factors for the development of CRC in IBD include disease duration of 8 years or more, family history of CRC, extensive colitis and primary sclerosing cholangitis. Meticulous colonoscopy and anti-inflammatory medications can reduce the risk of developing CRC. The future of IBD surveillance involves the use of novel endoscopic techniques (chromoendoscopy, narrow-band imaging, confocal laser endomicroscopy and autofluorescence) to enhance colonoscopic accuracy, in concert with chemopreventative medications to help reduce the risk of CRC in IBD.

AB - Inflammatory bowel disease (IBD) is a chronic gastrointestinal disease associated with an increased risk of colorectal cancer (CRC). Although CRC occurs in a minority of IBD patients (1%), it carries a high mortality and accounts for 20% of IBD-related mortality. Established risk factors for the development of CRC in IBD include disease duration of 8 years or more, family history of CRC, extensive colitis and primary sclerosing cholangitis. Meticulous colonoscopy and anti-inflammatory medications can reduce the risk of developing CRC. The future of IBD surveillance involves the use of novel endoscopic techniques (chromoendoscopy, narrow-band imaging, confocal laser endomicroscopy and autofluorescence) to enhance colonoscopic accuracy, in concert with chemopreventative medications to help reduce the risk of CRC in IBD.

KW - colorectal cancer

KW - dysplasia

KW - IBD

KW - inflammatory bowel disease

UR - http://www.scopus.com/inward/record.url?scp=79951626158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951626158&partnerID=8YFLogxK

U2 - 10.1586/egh.10.77

DO - 10.1586/egh.10.77

M3 - Review article

C2 - 21309672

AN - SCOPUS:79951626158

VL - 5

SP - 59

EP - 66

JO - Expert Review of Gastroenterology and Hepatology

JF - Expert Review of Gastroenterology and Hepatology

SN - 1747-4124

IS - 1

ER -